News/Dow Jones Newswires/Janux Therapeutics Price Target Raised to $27.00/Share From $26.00 by Truist SecuritiesJanux Therapeutics Price Target Raised to $27.00/Share From $26.00 by Truist SecuritiesRead the full articleGet unlimited access to articles from Dow Jones Newswires and every other news source on TradingView.Keep reading
